Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sialorrhea × Imiquimod × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 28 Uterine Cervical Dysplasia 12 Carcinoma, Basal Cell 12 Melanoma 7 Glioblastoma 6 Glioma 5 Breast Neoplasms 5 Uterine Cervical Neoplasms 4 Condylomata Acuminata 4 Precancerous Conditions 3 Papillomavirus Infections 3 Keratosis 3 Hutchinson's Melanotic Freckle 3 Vulvar Neoplasms 2 Urinary Bladder Neoplasms 2 Squamous Intraepithelial Lesions 2 Non-Muscle Invasive Bladder Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Hemangioma, Capillary 2 HIV Infections 2 Ependymoma 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Astrocytoma 2 Warts 1 Vulvar High Grade Squamous Intraepithelial Lesion (HSIL) 1 Virus Diseases 1 Vaginal Neoplasms 1 Stomach Neoplasms 1

Interventions

Imiquimod 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02234921 2018-10-11

DRibble

UbiVac

Phase 1 Completed

Adenocarcinoma, Neoplasm Metastasis, Sialorrhea

Data powered by HemOnc (CC BY 4.0) Colophon ⚡